POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,920,774 | +48.3% | 1,227,216 | +9.7% | 0.00% | – |
| Q2 2023 | $1,969,009 | +172.7% | 1,118,755 | +377.1% | 0.00% | – |
| Q1 2023 | $722,158 | -56.8% | 234,467 | -25.6% | 0.00% | – |
| Q4 2022 | $1,670,210 | +409.2% | 315,134 | +239.0% | 0.00% | – |
| Q3 2022 | $328,000 | +36.7% | 92,967 | 0.0% | 0.00% | – |
| Q2 2022 | $240,000 | -89.9% | 92,967 | -82.5% | 0.00% | – |
| Q1 2022 | $2,381,000 | -35.7% | 531,573 | -2.3% | 0.00% | – |
| Q4 2021 | $3,704,000 | -2.6% | 543,932 | +4.3% | 0.00% | – |
| Q3 2021 | $3,802,000 | -26.2% | 521,513 | +1.5% | 0.00% | – |
| Q2 2021 | $5,150,000 | +19.4% | 513,992 | +13.8% | 0.00% | – |
| Q1 2021 | $4,314,000 | +110.5% | 451,678 | +141.8% | 0.00% | – |
| Q4 2020 | $2,049,000 | +75.4% | 186,799 | +41.9% | 0.00% | – |
| Q3 2020 | $1,168,000 | – | 131,648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $9,254,000 | 2.96% |
| SECTORAL ASSET MANAGEMENT INC | 1,053,779 | $9,347,000 | 0.80% |
| Pentwater Capital Management LP | 4,879,490 | $43,281,000 | 0.56% |
| Vivo Capital, LLC | 926,449 | $8,218,000 | 0.48% |
| Boxer Capital, LLC | 1,251,055 | $11,097,000 | 0.38% |
| Ikarian Capital, LLC | 228,000 | $2,022,000 | 0.15% |
| Perceptive Advisors | 787,745 | $6,987,000 | 0.10% |
| Rock Springs Capital Management LP | 367,499 | $3,260,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 148,949 | $1,321,000 | 0.07% |
| PIPER SANDLER & CO. | 8,298 | $74,000 | 0.06% |